(Q73288539)

English

A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group

scientific article published on 01 November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

Gabriele Di Lorenzo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gianenrico Senna

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

C Ortolani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Foresi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Bagnato

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Bonifazi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Emmi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Prandini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Tursi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Mirone

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Leone

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Fina

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Testi

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1173-1180

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble markers of allergic inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the current guidelines for allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihistamines: topical vs oral administration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00200.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1398-9995.1999.00200.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10604553%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73288539&oldid=1984877188"